Although utility patents grant inventors a temporary monopoly, they can ultimately benefit patients by spurring the development of innovative therapies and technologies. The promise of patent protection can motivate companies to invest in high-risk cancer research, leading to breakthroughs that might not otherwise occur. Moreover, once a patent expires, other manufacturers can produce generic versions, increasing accessibility and reducing costs for patients.
